StockDuty ← Dashboard Jul 28, 2026 10:14 AM ET
CatalystFDA/Bio

CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology

Publication of pivotal Phase 3 BOND-003 results in The Lancet Oncology signals key clinical milestone.

What changed
Why it matters
Publication of pivotal Phase 3 BOND-003 results in The Lancet Oncology signals key clinical milestone.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →